Back to Search
Start Over
Evaluation of the clinical efficacy and safety of an imidacloprid 10 %/moxidectin 2.5 % spot-on formulation (Advocate®, Advantage® Multi) in comparison to an untreated control group in dogs naturally infected by Capillaria boehmi
- Publication Year :
- 2017
- Subjects :
- Capillaria boehmi, moxidectin, dog
Capillaria boehmi
dog
moxidectin
Subjects
Details
- Language :
- English
- Database :
- OpenAIRE
- Accession number :
- edsair.od......3664..8797ebae064167f13e0e08de549ac2d1